scispace - formally typeset
K

Kelly L. Jordan-Sciutto

Researcher at University of Pennsylvania

Publications -  69
Citations -  2651

Kelly L. Jordan-Sciutto is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Neurodegeneration & Neuroprotection. The author has an hindex of 25, co-authored 62 publications receiving 2289 citations.

Papers
More filters
Journal ArticleDOI

Expression of Nrf2 in Neurodegenerative Diseases

TL;DR: It is suggested that Nrf2-mediated transcription is not induced in neurons in AD despite the presence of oxidative stress, and in PD, nuclear localization of NRF2 is strongly induced, but this response may be insufficient to protect neurons from degeneration.
Journal ArticleDOI

HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.

TL;DR: By considering the specific mechanisms and consequences of HIV neuropathogenesis, unified approaches for neuroprotection will likely emerge using a tailored, combined, and non-invasive approach.
Journal ArticleDOI

Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system.

TL;DR: It is shown that ARVs are neurotoxic in the CNS in both pigtail macaques and rats in vivo and implicate oxidative stress as a contributor to the underlying mechanisms of ARV-induced neurotoxicity and will provide an access point for adjunctive therapies to complement ARV therapy and reduce neurotoxicity in this patient population.
Journal ArticleDOI

Human Immunodeficiency Virus (HIV)-Induced Neurotoxicity: Roles for the NMDA Receptor Subtypes

TL;DR: These studies establish a clear link between macrophage HIV infection, neuronal NR2A and NR2B activation, and calpain-mediated hippocampal neuronal death and suggest a dominant role for NR2a andNR2B in determining neuronal susceptibility in HIV-infected brain.
Journal ArticleDOI

Dimethyl Fumarate, an Immune Modulator and Inducer of the Antioxidant Response, Suppresses HIV Replication and Macrophage-Mediated Neurotoxicity: A Novel Candidate for HIV Neuroprotection

TL;DR: It is proposed that dysregulation of the antioxidant response during HIV infection drives macrophage-mediated neurotoxicity and that DMF could serve as an adjunctive neuroprotectant and HIV disease modifier in ART-treated individuals.